 Christopher Hoyte
Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Poison Control Centers | 15 | 2025 | 88 | 5.650 |
Why?
| | Acetaminophen | 9 | 2023 | 247 | 2.200 |
Why?
| | Poisons | 5 | 2023 | 20 | 2.140 |
Why?
| | Antivenins | 7 | 2025 | 35 | 1.860 |
Why?
| | Analgesics, Non-Narcotic | 5 | 2023 | 120 | 1.770 |
Why?
| | Drug Overdose | 8 | 2024 | 322 | 1.510 |
Why?
| | Biguanides | 2 | 2023 | 12 | 1.430 |
Why?
| | Cannabis | 6 | 2023 | 462 | 1.390 |
Why?
| | Snake Bites | 5 | 2025 | 28 | 1.360 |
Why?
| | Antidotes | 3 | 2022 | 136 | 1.250 |
Why?
| | Anaphylaxis | 3 | 2023 | 98 | 1.140 |
Why?
| | Toxicology | 3 | 2024 | 41 | 0.990 |
Why?
| | Emergency Service, Hospital | 9 | 2023 | 1914 | 0.980 |
Why?
| | Chemical and Drug Induced Liver Injury | 3 | 2022 | 132 | 0.980 |
Why?
| | Spider Venoms | 2 | 2017 | 11 | 0.960 |
Why?
| | Methadone | 2 | 2023 | 91 | 0.950 |
Why?
| | Anticonvulsants | 2 | 2019 | 209 | 0.950 |
Why?
| | Hydrazines | 1 | 2024 | 34 | 0.890 |
Why?
| | Substance-Related Disorders | 3 | 2019 | 1020 | 0.870 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2025 | 114 | 0.860 |
Why?
| | Energy Drinks | 2 | 2013 | 4 | 0.850 |
Why?
| | Hypoglycemic Agents | 3 | 2025 | 1221 | 0.850 |
Why?
| | Viper Venoms | 3 | 2021 | 9 | 0.820 |
Why?
| | Prescription Drugs | 2 | 2015 | 112 | 0.800 |
Why?
| | Abdominal Pain | 3 | 2023 | 143 | 0.790 |
Why?
| | Machine Learning | 3 | 2023 | 443 | 0.780 |
Why?
| | Analgesia | 1 | 2023 | 100 | 0.770 |
Why?
| | Adolescent | 24 | 2025 | 20412 | 0.760 |
Why?
| | Retrospective Studies | 24 | 2025 | 14522 | 0.760 |
Why?
| | Metformin | 3 | 2022 | 318 | 0.750 |
Why?
| | Ethylene Glycol | 1 | 2021 | 13 | 0.750 |
Why?
| | Designer Drugs | 2 | 2019 | 8 | 0.750 |
Why?
| | United States | 18 | 2025 | 13871 | 0.730 |
Why?
| | Databases, Factual | 2 | 2023 | 1269 | 0.710 |
Why?
| | Alcoholic Intoxication | 1 | 2021 | 63 | 0.700 |
Why?
| | Occupational Exposure | 1 | 2024 | 299 | 0.690 |
Why?
| | Young Adult | 18 | 2025 | 12455 | 0.690 |
Why?
| | Spider Bites | 2 | 2017 | 9 | 0.670 |
Why?
| | Black Widow Spider | 2 | 2017 | 9 | 0.670 |
Why?
| | Cannabinoids | 4 | 2018 | 154 | 0.670 |
Why?
| | Humans | 60 | 2025 | 129626 | 0.640 |
Why?
| | Hyperammonemia | 1 | 2019 | 16 | 0.630 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2019 | 33 | 0.630 |
Why?
| | Garlic | 1 | 2019 | 4 | 0.620 |
Why?
| | Acetylcysteine | 2 | 2022 | 146 | 0.620 |
Why?
| | Warts | 1 | 2019 | 5 | 0.620 |
Why?
| | Valproic Acid | 1 | 2019 | 47 | 0.620 |
Why?
| | Occlusive Dressings | 1 | 2019 | 5 | 0.620 |
Why?
| | Heart Arrest | 3 | 2023 | 320 | 0.620 |
Why?
| | Foot Diseases | 1 | 2019 | 16 | 0.620 |
Why?
| | Venoms | 1 | 2018 | 29 | 0.610 |
Why?
| | Carnitine | 1 | 2019 | 76 | 0.610 |
Why?
| | Seizures | 3 | 2024 | 401 | 0.610 |
Why?
| | Burns, Chemical | 1 | 2019 | 29 | 0.610 |
Why?
| | Bites and Stings | 1 | 2018 | 32 | 0.600 |
Why?
| | Foot Injuries | 1 | 2019 | 24 | 0.600 |
Why?
| | Brain Diseases | 1 | 2019 | 136 | 0.570 |
Why?
| | Pyridoxine | 1 | 2018 | 32 | 0.570 |
Why?
| | Dronabinol | 3 | 2023 | 203 | 0.570 |
Why?
| | Vitamin B Complex | 1 | 2018 | 41 | 0.560 |
Why?
| | Male | 32 | 2025 | 63670 | 0.560 |
Why?
| | Isoniazid | 1 | 2018 | 63 | 0.560 |
Why?
| | Abdominal Injuries | 1 | 2019 | 118 | 0.560 |
Why?
| | Decision Trees | 5 | 2023 | 90 | 0.540 |
Why?
| | Electrocardiography | 3 | 2024 | 611 | 0.520 |
Why?
| | Acidosis | 3 | 2024 | 89 | 0.520 |
Why?
| | Renal Insufficiency | 1 | 2018 | 150 | 0.520 |
Why?
| | Pain Measurement | 1 | 2018 | 508 | 0.510 |
Why?
| | Child, Preschool | 14 | 2024 | 10490 | 0.510 |
Why?
| | Antitubercular Agents | 1 | 2018 | 200 | 0.510 |
Why?
| | Adult | 22 | 2025 | 35599 | 0.490 |
Why?
| | Piracetam | 1 | 2015 | 13 | 0.480 |
Why?
| | Phenethylamines | 1 | 2015 | 23 | 0.480 |
Why?
| | Hallucinations | 1 | 2015 | 29 | 0.480 |
Why?
| | Sports | 2 | 2015 | 225 | 0.480 |
Why?
| | Sodium Channel Blockers | 1 | 2015 | 24 | 0.480 |
Why?
| | Amitriptyline | 1 | 2015 | 20 | 0.480 |
Why?
| | Tachycardia | 1 | 2015 | 57 | 0.480 |
Why?
| | Epilepsy | 2 | 2019 | 322 | 0.470 |
Why?
| | Food | 1 | 2016 | 156 | 0.470 |
Why?
| | Sodium Channels | 1 | 2015 | 66 | 0.470 |
Why?
| | Acetamides | 1 | 2015 | 36 | 0.470 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 66 | 0.460 |
Why?
| | Child | 21 | 2024 | 20884 | 0.450 |
Why?
| | Long QT Syndrome | 1 | 2015 | 67 | 0.450 |
Why?
| | Female | 26 | 2025 | 68734 | 0.440 |
Why?
| | Analgesics, Opioid | 4 | 2023 | 913 | 0.430 |
Why?
| | Performance-Enhancing Substances | 1 | 2013 | 9 | 0.420 |
Why?
| | Crotalid Venoms | 2 | 2025 | 31 | 0.420 |
Why?
| | Tachycardia, Ventricular | 1 | 2015 | 168 | 0.420 |
Why?
| | Caffeine | 1 | 2013 | 62 | 0.410 |
Why?
| | Diet Surveys | 1 | 2013 | 92 | 0.410 |
Why?
| | Israel | 4 | 2024 | 46 | 0.400 |
Why?
| | Ethylene Glycols | 1 | 2012 | 15 | 0.390 |
Why?
| | Hallucinogens | 2 | 2024 | 102 | 0.380 |
Why?
| | Middle Aged | 14 | 2025 | 31136 | 0.370 |
Why?
| | Athletes | 1 | 2015 | 411 | 0.370 |
Why?
| | Hypoglycemia | 3 | 2025 | 427 | 0.330 |
Why?
| | Vomiting | 3 | 2022 | 129 | 0.320 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2025 | 2442 | 0.310 |
Why?
| | Infant | 8 | 2022 | 8995 | 0.300 |
Why?
| | Aged | 10 | 2025 | 22061 | 0.290 |
Why?
| | Infusions, Intravenous | 2 | 2019 | 399 | 0.290 |
Why?
| | Incidence | 3 | 2021 | 2641 | 0.280 |
Why?
| | Crotalus | 2 | 2025 | 26 | 0.280 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2023 | 233 | 0.280 |
Why?
| | Poisoning | 3 | 2024 | 111 | 0.270 |
Why?
| | Reproducibility of Results | 3 | 2024 | 3080 | 0.260 |
Why?
| | Prognosis | 4 | 2022 | 3774 | 0.260 |
Why?
| | Sulfonylurea Compounds | 2 | 2023 | 46 | 0.250 |
Why?
| | Tertiary Healthcare | 3 | 2024 | 29 | 0.250 |
Why?
| | Colorado | 5 | 2019 | 4404 | 0.250 |
Why?
| | Physical Examination | 2 | 2018 | 234 | 0.240 |
Why?
| | Hospitals, Teaching | 1 | 2024 | 114 | 0.220 |
Why?
| | Glucagon-Like Peptides | 1 | 2025 | 50 | 0.220 |
Why?
| | Viperidae | 2 | 2021 | 7 | 0.220 |
Why?
| | Treatment Outcome | 5 | 2019 | 10219 | 0.220 |
Why?
| | Animals | 11 | 2025 | 35391 | 0.220 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2025 | 198 | 0.220 |
Why?
| | Plant Poisoning | 1 | 2023 | 9 | 0.220 |
Why?
| | Benzodiazepines | 3 | 2023 | 134 | 0.210 |
Why?
| | Epinephrine | 1 | 2023 | 141 | 0.200 |
Why?
| | Foodborne Diseases | 1 | 2023 | 48 | 0.200 |
Why?
| | Algorithms | 4 | 2023 | 1616 | 0.200 |
Why?
| | Support Vector Machine | 1 | 2022 | 38 | 0.200 |
Why?
| | Referral and Consultation | 2 | 2024 | 730 | 0.190 |
Why?
| | Medicine | 1 | 2024 | 119 | 0.190 |
Why?
| | Health Facilities | 1 | 2022 | 80 | 0.190 |
Why?
| | Cohort Studies | 3 | 2022 | 5426 | 0.190 |
Why?
| | Anesthesia | 1 | 2023 | 134 | 0.180 |
Why?
| | Age Factors | 2 | 2021 | 3152 | 0.180 |
Why?
| | Fentanyl | 1 | 2022 | 79 | 0.180 |
Why?
| | Hospitals, Pediatric | 3 | 2019 | 513 | 0.180 |
Why?
| | Prevalence | 2 | 2019 | 2564 | 0.170 |
Why?
| | Tramadol | 1 | 2020 | 10 | 0.170 |
Why?
| | Pain Management | 1 | 2023 | 324 | 0.170 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 253 | 0.160 |
Why?
| | Drug Administration Schedule | 2 | 2019 | 767 | 0.160 |
Why?
| | Mortality | 1 | 2021 | 307 | 0.160 |
Why?
| | Bacitracin | 1 | 2019 | 6 | 0.160 |
Why?
| | Mediterranean Sea | 1 | 2018 | 1 | 0.160 |
Why?
| | Scyphozoa | 1 | 2018 | 1 | 0.160 |
Why?
| | Regression Analysis | 1 | 2021 | 997 | 0.160 |
Why?
| | Medicine, Traditional | 1 | 2019 | 22 | 0.150 |
Why?
| | Ammonia | 1 | 2019 | 62 | 0.150 |
Why?
| | Bandages | 1 | 2019 | 32 | 0.150 |
Why?
| | Hyperlactatemia | 1 | 2018 | 3 | 0.150 |
Why?
| | Anti-Infective Agents, Local | 1 | 2019 | 42 | 0.150 |
Why?
| | Drug Packaging | 1 | 2019 | 41 | 0.150 |
Why?
| | Debridement | 1 | 2019 | 83 | 0.150 |
Why?
| | Cannabidiol | 1 | 2020 | 108 | 0.140 |
Why?
| | Medical Marijuana | 1 | 2020 | 111 | 0.140 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2018 | 40 | 0.140 |
Why?
| | Lead | 1 | 2018 | 56 | 0.140 |
Why?
| | Substance Abuse Detection | 1 | 2018 | 79 | 0.140 |
Why?
| | Clinical Protocols | 1 | 2019 | 254 | 0.140 |
Why?
| | Blood Coagulation | 1 | 2019 | 239 | 0.140 |
Why?
| | Administration, Intravenous | 1 | 2018 | 141 | 0.140 |
Why?
| | Liver Failure, Acute | 1 | 2018 | 66 | 0.140 |
Why?
| | Amyloid beta-Peptides | 1 | 2020 | 211 | 0.140 |
Why?
| | Preventive Health Services | 1 | 2018 | 145 | 0.130 |
Why?
| | Physician's Role | 1 | 2018 | 206 | 0.130 |
Why?
| | Longitudinal Studies | 1 | 2023 | 2720 | 0.130 |
Why?
| | Seasons | 1 | 2018 | 494 | 0.130 |
Why?
| | Acute Disease | 1 | 2019 | 979 | 0.120 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 171 | 0.120 |
Why?
| | Drug Therapy, Combination | 1 | 2018 | 1042 | 0.120 |
Why?
| | Serotonin Syndrome | 1 | 2015 | 5 | 0.120 |
Why?
| | Clozapine | 1 | 2015 | 21 | 0.120 |
Why?
| | Serotonin Antagonists | 1 | 2015 | 31 | 0.120 |
Why?
| | Sertraline | 1 | 2015 | 30 | 0.120 |
Why?
| | Age Distribution | 1 | 2016 | 373 | 0.120 |
Why?
| | Mental Disorders | 1 | 2024 | 1034 | 0.120 |
Why?
| | Marijuana Use | 1 | 2018 | 192 | 0.120 |
Why?
| | Sodium Bicarbonate | 1 | 2015 | 37 | 0.120 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2015 | 44 | 0.120 |
Why?
| | Registries | 4 | 2025 | 1899 | 0.120 |
Why?
| | Hemorrhage | 1 | 2019 | 680 | 0.110 |
Why?
| | Critical Illness | 1 | 2020 | 758 | 0.110 |
Why?
| | Pandemics | 1 | 2022 | 1491 | 0.110 |
Why?
| | Alzheimer Disease | 1 | 2020 | 514 | 0.110 |
Why?
| | Drug Interactions | 1 | 2015 | 395 | 0.110 |
Why?
| | Physician-Patient Relations | 1 | 2018 | 540 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 1001 | 0.110 |
Why?
| | Indazoles | 1 | 2014 | 66 | 0.110 |
Why?
| | Aged, 80 and over | 2 | 2022 | 7052 | 0.100 |
Why?
| | Hospital Mortality | 3 | 2023 | 848 | 0.100 |
Why?
| | Adolescent Behavior | 1 | 2018 | 507 | 0.100 |
Why?
| | Lithium | 2 | 2023 | 37 | 0.100 |
Why?
| | Diphenhydramine | 2 | 2023 | 31 | 0.100 |
Why?
| | Risk Factors | 3 | 2015 | 9786 | 0.100 |
Why?
| | North America | 2 | 2025 | 292 | 0.100 |
Why?
| | Immunoglobulin G | 1 | 2017 | 851 | 0.100 |
Why?
| | Calcium Channel Blockers | 2 | 2023 | 161 | 0.100 |
Why?
| | Athletic Performance | 1 | 2013 | 77 | 0.100 |
Why?
| | Firearms | 1 | 2018 | 361 | 0.090 |
Why?
| | Suicide, Attempted | 1 | 2015 | 356 | 0.090 |
Why?
| | Horses | 2 | 2022 | 107 | 0.090 |
Why?
| | Kidney | 1 | 2018 | 1386 | 0.090 |
Why?
| | Infant, Newborn | 2 | 2022 | 5756 | 0.090 |
Why?
| | Universities | 1 | 2013 | 409 | 0.090 |
Why?
| | Mass Screening | 1 | 2018 | 1190 | 0.090 |
Why?
| | Blood Glucose | 1 | 2020 | 2100 | 0.080 |
Why?
| | Data Collection | 1 | 2013 | 650 | 0.080 |
Why?
| | Eating | 2 | 2023 | 368 | 0.080 |
Why?
| | Emergency Medical Services | 1 | 2015 | 522 | 0.080 |
Why?
| | Pyrazoles | 1 | 2012 | 404 | 0.080 |
Why?
| | Students | 1 | 2013 | 582 | 0.070 |
Why?
| | Primary Health Care | 1 | 2018 | 1686 | 0.070 |
Why?
| | Pilot Projects | 2 | 2023 | 1592 | 0.070 |
Why?
| | Sex Factors | 1 | 2013 | 1970 | 0.070 |
Why?
| | Time Factors | 1 | 2018 | 6555 | 0.070 |
Why?
| | Naloxone | 2 | 2020 | 112 | 0.070 |
Why?
| | Shoulder Dislocation | 1 | 2008 | 49 | 0.070 |
Why?
| | Nortriptyline | 1 | 2024 | 11 | 0.060 |
Why?
| | Quetiapine Fumarate | 1 | 2024 | 23 | 0.060 |
Why?
| | Xenobiotics | 1 | 2024 | 29 | 0.050 |
Why?
| | Digoxin | 1 | 2023 | 28 | 0.050 |
Why?
| | Tertiary Care Centers | 1 | 2024 | 148 | 0.050 |
Why?
| | Bradycardia | 1 | 2023 | 53 | 0.050 |
Why?
| | Psychotropic Drugs | 1 | 2023 | 69 | 0.050 |
Why?
| | Bupropion | 1 | 2022 | 40 | 0.050 |
Why?
| | Documentation | 1 | 2024 | 184 | 0.050 |
Why?
| | Guidelines as Topic | 1 | 2024 | 264 | 0.050 |
Why?
| | Vertigo | 1 | 2022 | 38 | 0.050 |
Why?
| | American Heart Association | 1 | 2023 | 300 | 0.050 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2022 | 59 | 0.050 |
Why?
| | Nausea | 1 | 2022 | 111 | 0.050 |
Why?
| | Tremor | 1 | 2022 | 60 | 0.050 |
Why?
| | Dizziness | 1 | 2022 | 80 | 0.050 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2023 | 321 | 0.050 |
Why?
| | Arrhythmias, Cardiac | 1 | 2024 | 320 | 0.050 |
Why?
| | Consensus | 1 | 2024 | 618 | 0.040 |
Why?
| | Diarrhea | 1 | 2022 | 182 | 0.040 |
Why?
| | Mice | 1 | 2018 | 16961 | 0.040 |
Why?
| | Prospective Studies | 2 | 2023 | 7135 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 5415 | 0.040 |
Why?
| | Coma | 1 | 2020 | 32 | 0.040 |
Why?
| | Nomograms | 1 | 2020 | 47 | 0.040 |
Why?
| | Creatinine | 1 | 2022 | 490 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2024 | 712 | 0.040 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2020 | 61 | 0.040 |
Why?
| | Aspirin | 1 | 2022 | 380 | 0.040 |
Why?
| | Sheep | 1 | 2022 | 845 | 0.040 |
Why?
| | Hospitals | 1 | 2024 | 637 | 0.040 |
Why?
| | Respiratory Insufficiency | 1 | 2020 | 313 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2024 | 973 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2020 | 327 | 0.030 |
Why?
| | Exercise | 1 | 2008 | 1928 | 0.030 |
Why?
| | Edema | 1 | 2017 | 124 | 0.030 |
Why?
| | Near Drowning | 1 | 2015 | 1 | 0.030 |
Why?
| | Cardiac Tamponade | 1 | 2015 | 14 | 0.030 |
Why?
| | Hypotension | 1 | 2017 | 116 | 0.030 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2015 | 28 | 0.030 |
Why?
| | Hypothermia | 1 | 2015 | 34 | 0.030 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2015 | 78 | 0.030 |
Why?
| | Water-Electrolyte Imbalance | 1 | 2015 | 42 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 5075 | 0.030 |
Why?
| | Pulmonary Embolism | 1 | 2015 | 212 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2011 | 0.020 |
Why?
| | Pain | 1 | 2017 | 787 | 0.020 |
Why?
| | Hospitalization | 1 | 2020 | 2057 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 2014 | 349 | 0.020 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2015 | 467 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 2015 | 711 | 0.020 |
Why?
| | Manipulation, Orthopedic | 1 | 2008 | 7 | 0.020 |
Why?
| | Shoulder Pain | 1 | 2008 | 32 | 0.020 |
Why?
| | Brain | 1 | 2020 | 2673 | 0.020 |
Why?
| | Muscle Fatigue | 1 | 2008 | 99 | 0.020 |
Why?
| | Radiography | 1 | 2008 | 797 | 0.020 |
Why?
| | Pregnancy | 1 | 2015 | 6417 | 0.010 |
Why?
| | Athletic Injuries | 1 | 2008 | 510 | 0.010 |
Why?
|
|
Hoyte's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|